Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Website: thermofisher.com


  • Pretty weak financial results growth rate 1.2% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-0.7%)
  • Dividend yield for the last twelve months 0.4%
  • Free cash flow yield -0.7% (LTM)
  • Share price is 22.6% higher than minimum and 23.4% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (19.3x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $0.3 mln (0.000% of cap.)

Key Financials (Download financials)

Ticker: TMO
Share price, USD:  (+0.7%)478.32
year average price 516.73  


year start price 607.14 2024-07-27

max close price 624.21 2024-09-10

min close price 390.26 2025-06-17

current price 478.32 2025-07-26
Common stocks: 391 000 000

Dividend Yield:  0.4%
FCF Yield LTM: -0.7%
EV / LTM EBITDA: 19.3x
EV / EBITDA annualized: 22.7x
Last revenue growth (y/y):  +0.2%
Last growth of EBITDA (y/y):  +2.3%
Historical revenue growth:  +1.8%
Historical growth of EBITDA:  -3.2%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 187 023
Net Debt ($m): -5 849
EV (Enterprise Value): 181 174
EBITDA LTM ($m): 9 369
EV / LTM EBITDA: 19.3x
Price to Book: 3.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-07-23investopedia.com

Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook

2025-07-23proactiveinvestors.com

Thermo Fisher shares surge after Q2 beat, boosted by product launches

2025-07-23zacks.com

Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market

2025-07-23zacks.com

Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates

2025-07-22globenewswire.com

Thermo Fisher Scientific Company Analysis Report | Key Milestones/History, Product Offerings, Technologies, Major Applications and End-user Industries

2025-07-18zacks.com

Thermo Fisher (TMO) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

2025-07-18zacks.com

TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus

2025-07-07seekingalpha.com

Thermo Fisher Scientific: Recovery In Sight, Attractively Valued

2025-06-13businesswire.com

Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms

2025-06-12reuters.com

Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data